Library / regulatory-reference
Chile: Public Health Institute of Chile (ISP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Public Health Institute of Chile, known as ISP, is the country's national regulator for medicines, biological products, medical devices and a broad range of health products, a technical-scientific institute under the Ministry of Health with roots going back more than a century.
The institute combines regulatory authority with national public-health laboratory functions, giving it an unusual dual identity: it both authorizes products and runs reference laboratories serving the country's health system.
How products enter the market
Medicines require a sanitary registration granted after evaluation of quality, safety and efficacy, with the institute's own laboratories able to verify product quality directly, a capability that distinguishes it from purely administrative regulators.
Medical devices require registration with risk-based requirements, and the institute supervises pharmacies and establishments and runs the national pharmacovigilance system, drawing on its laboratory arm for post-market quality testing.
Regional and international role
The ISP is one of Latin America's reference regulators: its laboratory-backed evaluation model is internationally respected, and Chile's system is frequently cited in regional reliance arrangements.
The institute participates in international harmonization networks and its blood, vaccine and biological-product oversight is closely integrated with the national immunization program.
Using this profile
The institute publishes registers, guidance and alerts in Spanish through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the ISP illustrates the laboratory-regulator hybrid: an authority that can test what it registers, pairing market authorization with national reference-laboratory functions in one institution.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.